Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming

Veterinary Microbiology

Volumn 121, Issue 1-2, 2007, Pages 94-104

  Marien, Maja ^a   Decostere, Annemie ^a   Duchateau, Luc ^a   Chiers, Koen ^a   Froyman, Robrecht ^b   Nauwynck, Hans ^a  

^a GHENT UNIVERSITY   (Belgium)

^b BAYER PHARMA AG   (Germany)

Author keywords

Antimicrobial treatment; Avian metapneumovirus; Escherichia coli O2:K1; Ornithobacterium rhinotracheale; Turkeys

Indexed keywords

AMOXICILLIN; DRINKING WATER; ENROFLOXACIN; FLORFENICOL; SURAMOX 50; UNCLASSIFIED DRUG;

AIR SAC; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; AVIAN PNEUMOVIRUS; BACTERIAL INFECTION; BACTERIUM ISOLATION; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HEART; HISTOPATHOLOGY; INOCULATION; LIVER; LUNG PARENCHYMA; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORNITHOBACTERIUM; ORNITHOBACTERIUM RHINOTRACHEALE; PARANASAL SINUS; PERICARDIUM; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT DISEASE; TRACHEA; TREATMENT DURATION; TURBINATE; TURKEY (BIRD); VIRUS TITRATION;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BODY WEIGHT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLAVOBACTERIACEAE INFECTIONS; FLUOROQUINOLONES; METAPNEUMOVIRUS; MICROBIAL SENSITIVITY TESTS; ORNITHOBACTERIUM; PARAMYXOVIRIDAE INFECTIONS; POULTRY DISEASES; RESPIRATORY TRACT DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; THIAMPHENICOL; TRACHEA; TURKEYS;

AVES; AVIAN METAPNEUMOVIRUS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ORNITHOBACTERIUM RHINOTRACHEALE;

EID: 33847335118     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.11.012     Document Type: Article

References (27)

1. Anadón A., Martinez-Larrañaga M.R., Diaz M.J., Bringas P., Fernandez M.C., Martinez M.A., and Fernandez-Cruz M.L. Pharmacokinetics of amoxicillin in broiler chickens. Avian Pathol. 25 (1996) 449-458
2. Afifi N.A., and El-Sooud K.A. Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens. Br. Poult. Sci. 38 (1997) 425-428
3. Agresti A. Categorical Data Analysis. 2nd ed. (2002), John Wiley & Sons, Inc., Hoboken, NJ p. 514
4. Brown S.A. Fluoroquinolones in animal health. J. Vet. Pharmacol. Ther. 19 (1996) 1-14
5. Bugyei K., Black W.D., and McEwen S. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens. Can. J. Vet. Res. 63 (1999) 193-200
6. Carceles C.M., Vicente M.S., and Escudero E. Pharmacokinetics of amoxicillin-clavulanic acid combination after intravenous and intramuscular administration to turkeys and chickens. Avian Pathol. 24 (1995) 643-952
7. Charleston B., Bate J.J., Aitken I.A., Stephan B., and Froyman R. Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens. Antimicrob. Agents Chemother. 42 1 (1998) 83-87
8. Cox S.K., Cottrell M.B., Smith L., Papich M.G., Frazier D.L., and Bartges J. Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species. J. Vet. Pharmacol. Ther. 27 (2004) 139-146
9. Devriese L.A., De Herdt P., and Haesebrouck F. Antibiotic sensitivity and resistance in Ornithobacterium rhinotracheale strains from Belgian broiler chickens. Avian Pathol. 30 (2001) 197-200
10. Dimitrova D.J., Lashev L.D., Janev St.G., and Pandova V.D. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in male and female turkeys following intravenous and oral administration. Vet. Res. Commun. 30 4 (2006) 415-422
11. Froyman R., and Cooper J. Assessment of the efficacy of fluoroquinolones and other antimicrobials against respiratory colibacillosis and septicemia in chickens under standardized challenge conditions. Proceedings of the XIII Congress of the WPVA. Denver, CO, USA (2003) 84
12. Garcia Ovando H., Gorla N., Luders C., Poloni G., Errecalde C., Prieto G., and Puelles I. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in chickens. J. Vet. Pharmacol. Ther. 22 (1999) 209-212
13. Goren E., De Jong W.A., and Van Solkema A. Some pharmacokinetical aspects of ampicillin trihydrate and its therapeutic efficacy in experimental Escherichia coli infection in poultry. Avian Pathol. 10 (1981) 43-55
14. Hafez H.M., and Sting R. Investigations on different Ornithobacterium rhinotracheale "ORT" isolates. Avian Dis. 34 1 (1999) 1-7
15. Hafez H.M. Current knowledge and prospective risk analysis related to the ongoing turkey diseases. Proceedings of the 14th Veterinary Poultry Congress. Istanbul, Turkey (2005) 138-149
16. Knoll U., Glünder G., and Kietzmann M. Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens. J. Vet. Pharmacol. Ther. 22 (1999) 239-246
17. Lashev L.D., and Pashov D.A. Interspecies variations in plasma half-life of ampicillin, amoxicillin, sulphadimidine and sulphacetamide related to variations in body mass. Res. Vet. Sci. 53 (1992) 160-164
18. Marien M., Decostere A., Martel A., Chiers K., Froyman R., and Nauwynck H. Synergy between avian pneumovirus and Ornithobacterium rhinotracheale in turkeys. Avian Pathol. 34 3 (2005) 204-211
19. Marien M., Nauwynck H., Duchateau L., Martel A., Chiers K., Devriese L., Froyman R., and Decostere A. Comparison of the efficacy of four antimicrobial treatment schemes against experimental Ornithobacterium rhinotracheale infection in turkey poults pre-infected with avian pneumovirus. Avian Pathol. 35 3 (2006) 230-237
20. McKellar Q.A. Clinical relevance of the pharmacologic properties of fluoroquinolones. Compend. Contin. Educ. Pract. Vet. 18 2 (1996) 492-497
21. Rios A., Martínez-Larrañaga M.R., and Anadón A. Plasma disposition of florfenicol in broiler chickens following intravenous administration. J. Vet. Pharmacol. Ther. 20 Suppl. 1 (1997) 182
22. Shen J., Wu X., Hu D., and Jizng H. Pharmacokinetics of florfenicol in healthy and Escherichia coli-infected broiler chickens. Res. Vet. Sci. 73 (2002) 137-140
23. Shen J., Hu D., Wu X., and Coats J.R. Bioavailability and pharmacokinetics of florfenicol in broiler chickens. J. Vet. Pharmacol. Ther. 26 (2003) 337-341
24. Switala M., Okoniewski P., Smutkiewicz A., Jaworski K., and Hrynyk R. Pharmacokinetics of florfenicol and thiamphenicol in turkeys. Proceedings of the Second International Conference on Antimicrobial Agents in Veterinary Medicine (AAVM). Ottawa, Canada (2004) 99
25. Van de Zande S., Nauwynck H., Cavanagh D., and Pensaert M. Infections and reinfections with avian pneumovirus subtype A and B on Belgian turkey farms and relation to respiratory problems. J. Vet. Med. Ser. B: Infect. Dis. Vet. Public Health 45 (1998) 621-626
26. Van de Zande S., Nauwynck H., and Pensaert M. The clinical, pathological and microbiological outcome of an Escherichia coli O2:K1 infection in avian pneumovirus infection in turkeys. Vet. Microbiol. 81 (2001) 353-365
27. van Empel P.C.M., and Hafez H.M. Ornithobacterium rhinotracheale: a review. Avian Pathol. 28 (1999) 217-227